kidney function and chronic kidney disease. Nat Genet 42: 376–384. 15. Pattaro C, Kottgen A, Teumer A, Garnaas M, Boger CA, et al. (2012) Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 8: e1002584. doi:10.1371/journal.pgen.1002584 16. Bo¨ger C, Gorski M, Li M, Hoffmann M, Huang C, et al. (2011) Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet 7: e1002292. doi:10.1371/ journal.pgen.1002292 17. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier- Schaad Y, et al. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185–1192. 18. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomer- ulosclerosis. Nat Genet 40: 1175–1184. 19. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Ko¨ttgen A, et al. (2011) Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364: 616–626. 20. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, et al. (2011) Genome-wide association study identi- fies susceptibility loci for IgA nephropathy. Nat Genet 43: 321–327. 21. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, et al. (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367: 214–223. 22. Genovese G, Friedman DJ, Ross MD, Le- cordier L, Uzureau P, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841–845. 23. Remuzzi G, Benigni A, Remuzzi A (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288–296. 24. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, et al. (2005) The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric pa- tients. Diabetes 54: 2164–2171. 25. Perkins BA, Ficociello LH, Roshan B, Warram JH, Krolewski AS (2010) In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 77: 57–64. PLOS Genetics | www.plosgenetics.org 3 September 2012 | Volume 8 | Issue 9 | e1002989